Robbins J B, Schneerson R, Szu S C
Laboratory of Developmental and Molecular Immunity National Institute of Child Health and Human Development, NIH, Bethesda, Maryland 20892, USA.
Adv Exp Med Biol. 1996;397:169-82. doi: 10.1007/978-1-4899-1382-1_22.
By examining experience with evaluation of licensed vaccines we theorize that a critical level of serum IgG confers protection against infectious diseases by killing or inactivating the inoculum. We found that efficacy is reliably predicted by measurement of serum antibodies elicited by vaccines, that serum IgG antibodies alone account for the protection conferred by passive immunization, that vaccine-induced "herd" immunity is best explained by inactivation of the inoculum on epithelial surfaces by serum antibodies and that serum antibodies induced by active immunization will neither treat disease symptoms nor eliminate the pathogen. If valid, this theory should facilitate research because knowledge of the pathogenesis of the disease symptoms may not be essential for vaccine development.
通过研究已获许可疫苗的评估经验,我们推测血清IgG的临界水平可通过杀死接种物或使其失活来预防传染病。我们发现,通过测量疫苗引发的血清抗体能够可靠地预测疫苗效力;被动免疫所提供的保护仅由血清IgG抗体介导;疫苗诱导的“群体”免疫最好的解释是血清抗体使上皮表面的接种物失活;主动免疫诱导的血清抗体既不能治疗疾病症状也不能清除病原体。如果这一理论成立,将有助于开展研究,因为对于疫苗开发而言,了解疾病症状的发病机制可能并非至关重要。